349 related articles for article (PubMed ID: 15816456)
1. Local recurrence and survival rates after extended systematic lymph-node dissection for surgical treatment of rectal cancer.
Hasdemir O; Cöl C; Yalçin E; Tunç G; Bilgen K; Kuçukpinar T
Hepatogastroenterology; 2005; 52(62):455-9. PubMed ID: 15816456
[TBL] [Abstract][Full Text] [Related]
2. Lateral lymph node dissection for lower rectal cancer.
Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T
Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction after curative radical resection of rectal cancer in men: the role of extended systematic lymph-node dissection.
Cöl C; Hasdemir O; Yalçin E; Yandakçi K; Tunç G; Kuçukpinar T
Med Sci Monit; 2006 Feb; 12(2):CR70-4. PubMed ID: 16449950
[TBL] [Abstract][Full Text] [Related]
7. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
8. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
9. Locally recurrent rectal cancer after curative resection.
Christoforidis E; Kanellos I; Tsachalis T; Blouhos K; Lamprou I; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s132-4. PubMed ID: 15655597
[TBL] [Abstract][Full Text] [Related]
10. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
11. [Recurrence and survival after conventional low anterior resection for rectal cancer].
Bülow S; Moesgaard FA; Crone PO; Gandrup P; Holm J; Kronborg O; Hemmert-Lund H; Myrhøj T; Petersen RH; Qvist N; Raskov HH; Thomsen H
Ugeskr Laeger; 2001 Jul; 163(27):3793-7. PubMed ID: 11466988
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
13. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients.
Piso P; Dahlke MH; Mirena P; Schmidt U; Aselmann H; Schlitt HJ; Raab R; Klempnauer J
J Surg Oncol; 2004 Jun; 86(3):115-21. PubMed ID: 15170648
[TBL] [Abstract][Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
15. Surgical strategy for local recurrence after resection of rectal cancer.
Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S
Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677
[TBL] [Abstract][Full Text] [Related]
16. The influence of type of operation for distal rectal cancer: survival, outcomes, and recurrence.
Chiappa A; Biffi R; Zbar AP; Bertani E; Luca F; Pace U; Biella F; Grassi C; Zampino G; Fazio N; Pruneri G; Poldi D; Venturino M; Andreoni B
Hepatogastroenterology; 2007 Mar; 54(74):400-6. PubMed ID: 17523284
[TBL] [Abstract][Full Text] [Related]
17. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method.
Hida J; Yasutomi M; Fujimoto K; Maruyama T; Okuno K; Shindo K
J Am Coll Surg; 1997 May; 184(5):475-80. PubMed ID: 9145067
[TBL] [Abstract][Full Text] [Related]
18. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
[TBL] [Abstract][Full Text] [Related]
19. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence following curative low anterior resection for rectal carcinoma.
Safioleas MC; Moulakakis KG; Stamatakos M; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2005; 52(61):94-6. PubMed ID: 15783003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
